Xander M.R. van Wijk

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients”.

Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients

The Oncologist(2021)10.1002/onco.13953

N/A

0.520DataRank · unranked

31 citations

Keith Danahey, Emily Schierer, Ping Liu, Merisa Middlestadt, Jenna Ludwig +7 more

Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients

Journal of Personalized Medicine(2021)10.3390/jpm11121343

N/A

0.307DataRank · unranked

6 citations

Keith Danahey, Merisa Middlestadt, Kevin J. O’Leary, Edith A. Nutescu, Tai C. Chen +16 more

Pharmacogenomic‐Based Decision Support to Predict Adherence to Medications

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1838

N/A

0DataRank · unranked

22 citations

Brittany A. Borden, Keith Danahey, Kiang-Teck J Yeo, Xander M.R. van Wijk, Mark J. Ratain +2 more

Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform

The Journal of Applied Laboratory Medicine(2021)10.1093/jalm/jfab056

N/A

0DataRank · unranked

13 citations

Xun Pei, David L. George, Larry House, Keith Danahey, Elizabeth Lipschultz +5 more